Article Details

Repare Therapeutics continues climb following Roche licensing deal; shares up 40%

Retrieved on: 2022-06-02 18:59:33

Tags for this article:

Click the tags to see associated articles and topics

Repare Therapeutics continues climb following Roche licensing deal; shares up 40%. View article details on HISWAI: https://seekingalpha.com/news/3845201-repare-therapeutics-continues-climb-following-roche-licensing-deal-shares-up-40

Excerpt

Repare Therapeutics (RPTX) is continuing to benefit Thursday from a licensing deal with Roche (RHHBY) announced after the closing bell Wednesday.

Article found on: seekingalpha.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up